What is it about?
This paper defines unmet clinical need in the context of biomarker development. Using an outcome-focused approach, the paper provides a strategy and checklist for needs assessment intended for use by multiple stakeholders.
Featured Image
Why is it important?
This paper addresses the often neglected pre-discovery phase of medical test evaluation; identifying and validating unmet clinical needs in the development of novel biomarkers.
Perspectives
Read the Original
This page is a summary of: Biomarker development targeting unmet clinical needs, Clinica Chimica Acta, September 2016, Elsevier,
DOI: 10.1016/j.cca.2016.06.037.
You can read the full text:
Contributors
The following have contributed to this page